← SynDRA
GGTI-298
SynDRA canonical compound SYN1958656 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | CDKN1A |
| Mechanism of action | GGTase inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- Ggti 298
- GGTI298
- CHEMBL282748
- N-4-[2(R)-Amino-3-mercaptopropyl]amino-2-naphthylbenzoyl-(L)-Leucine methyl ester, TFA
- (S)-methyl 2-(4-((R)-2-amino-3-mercaptopropylamino)-2-(naphthalen-1-yl)benzamido)-4-methylpentanoate
- SCHEMBL4283635
- CHEBI:124997
- EX-A2390
- ZINC1488051
- BCP24854
- BDBM50076138
- AKOS032945065
- CS-6098
- NCGC00165800-01
- HY-100876
- BRD-K19669037-019-01-3
- 2-[4-((R)-2-Amino-3-mercapto-propylamino)-2-naphthalen-1-yl-benzoylamino]-4-methyl-pentanoic acid (S)-methyl ester
Look up GGTI-298 in the interactive SynDRA portal →